BSE Live
Nov 04, 16:01Prev. Close
443.50
Open Price
445.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 04, 15:44Prev. Close
443.85
Open Price
447.90
Bid Price (Qty.)
443.25 (1)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Venus Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 39.32 | 22.82 | 21.67 | 37.12 | 43.97 | |
| Diluted EPS (Rs.) | 39.32 | 22.82 | 21.67 | 37.12 | 43.97 | |
| Cash EPS (Rs.) | 55.49 | 41.94 | 45.14 | 61.02 | 71.75 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 441.01 | 380.48 | 357.63 | 336.21 | 324.24 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 441.01 | 380.48 | 357.63 | 336.21 | 324.24 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 478.39 | 430.32 | 402.23 | 430.30 | 416.97 | |
| PBDIT/Share (Rs.) | 67.91 | 54.02 | 53.64 | 57.79 | 52.36 | |
| PBIT/Share (Rs.) | 51.74 | 34.90 | 30.17 | 33.42 | 24.59 | |
| PBT/Share (Rs.) | 59.16 | 34.90 | 30.17 | 33.42 | 33.27 | |
| Net Profit/Share (Rs.) | 39.32 | 22.82 | 21.67 | 36.65 | 43.97 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 14.19 | 12.55 | 13.33 | 13.43 | 12.55 | |
| PBIT Margin (%) | 10.81 | 8.11 | 7.50 | 7.76 | 5.89 | |
| PBT Margin (%) | 12.36 | 8.11 | 7.50 | 7.76 | 7.97 | |
| Net Profit Margin (%) | 8.21 | 5.30 | 5.38 | 8.51 | 10.54 | |
| Return on Networth / Equity (%) | 8.91 | 5.99 | 6.05 | 10.90 | 13.56 | |
| Return on Capital Employed (%) | 11.37 | 8.20 | 7.52 | 9.00 | 6.61 | |
| Return on Assets (%) | 7.36 | 4.75 | 4.75 | 8.46 | 9.92 | |
| Total Debt/Equity (X) | 0.00 | 0.08 | 0.08 | 0.09 | 0.12 | |
| Asset Turnover Ratio (%) | 0.94 | 0.92 | 0.91 | 1.02 | 94.11 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.14 | 4.96 | 4.38 | 3.20 | 2.41 | |
| Quick Ratio (X) | 3.19 | 3.34 | 2.82 | 1.68 | 1.04 | |
| Inventory Turnover Ratio (X) | 5.86 | 4.97 | 2.65 | 3.04 | 4.30 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 322.49 | 407.33 | 202.58 | 348.08 | 358.63 | |
| EV/Net Operating Revenue (X) | 0.50 | 0.71 | 0.38 | 0.61 | 0.70 | |
| EV/EBITDA (X) | 3.55 | 5.64 | 2.83 | 4.51 | 5.55 | |
| MarketCap/Net Operating Revenue (X) | 0.63 | 0.76 | 0.40 | 0.62 | 0.66 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.68 | 0.86 | 0.45 | 0.80 | 0.85 | |
| Price/Net Operating Revenue | 0.63 | 0.76 | 0.40 | 0.62 | 0.66 | |
| Earnings Yield | 0.13 | 0.07 | 0.13 | 0.14 | 0.16 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y